In one of the biggest breakthroughs in schizophrenia research in recent times, Professor Cynthia Shannon Weickert at Neuroscience Research Australia (NeuRA) has identified immune cells in greater amounts in the brains of some people with schizophrenia. The study published today in Molecular Psychiatry has the potential to transform global schizophrenia research and open new avenues for developing targeted immune cell therapies.
One in every 100 Australians lives with schizophrenia. No single cause of schizophrenia has been identified, and this has prevented the development of a cure. The current treatments for schizophrenia are designed to suppress symptoms rather than target underlying causes of the disorder. These drugs only partially relieve symptoms and can produce unwanted side effects.
To recognise the significance of this discovery Professor Shannon Weickert says you first need to understand most scientists have had a long held belief that immune cells were independent from the brain pathology in psychotic illnesses.
“In our study, we challenged this assumption that immune cells were independent of the brain in psychiatric illness and made an exciting discovery. We identified immune cells as a new player in the brain pathology of schizophrenia,” said Professor Shannon Weickert.
Current schizophrenia research has focused on the status of three brain cells: the neurons; the glial cells, which support the neurons; and the endothelial cells, which coat the blood vessels. Employing new molecular techniques allowed Professor Shannon Weickert and her team to identify the presence of a fourth cell, the macrophage, a type of immune cell in the brain tissue of people with schizophrenia who show high levels of inflammation.
Professor Shannon Weickert said immune cells have previously been ignored as they had long been viewed simply as travelers just thought to be passing by, undertaking surveillance work. They have never been a suspect until now.
“To find immune cells along the blood brain barrier in increased amounts in people with schizophrenia is an exciting discovery. It suggests immune cells themselves may be producing these inflammatory signals in the brains of people living with schizophrenia,” said Professor Shannon Weickert.
“We have observed in people with schizophrenia, the glial cells, one of the local residents, become inflamed and produce distress signals which change the status of the endothelial cells.
“We think this may cause the endothelial cells to extend sticky tentacles, so when the immune cells travel by some are captured. These cells may transmigrate across the blood brain barrier entering the brain in greater amounts in some people with schizophrenia compared to people without the disorder.”
This discovery shows that specific immune cells are in the brains of some people with schizophrenia in close enough proximity to the neurons to do damage.
Professor Peter Schofield, CEO of NeuRA said this innovative new research has the ability to alter the way in which we may be able to diagnose and treat schizophrenia.
“This breakthrough demonstrates the value of the NSW Government’s support for Professor Shannon Weickert as NSW Chair of Schizophrenia Research, which has delivered new insights that the community seeks,” said Professor Schofield.
Professor Shannon Weickert is encouraging a cross-collaborative approach between neuroscientists and immunologists globally, to work together to develop treatments targeting this abnormal immune pathology of schizophrenia.
“This opens whole new avenues for therapy, because it suggests that the pathology of schizophrenia could be within the immune cells and the immune cells could be contributing to the symptoms of schizophrenia,” said Professor Shannon Weickert.
Professor Shannon Weickert is uniquely motivated in her work, with her twin-brother being diagnosed with schizophrenia when he was 17 years old.
Learn more: Schizophrenia breakthrough
The Latest on: Schizophrenia
via Google News
The Latest on: Schizophrenia
- Royalty Pharma Acquires Royalty Interest in Seltorexant From Minerva Neuroscienceson January 19, 2021 at 10:11 pm
(GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Minerva Neurosciences, Inc. (Nasdaq: NERV) today announced that Royalty Pharma will acquire Minerva’s royalty interest in seltorexant for an ...
- Parkinson's disease may up schizophrenia risk: Studyon January 16, 2021 at 2:36 am
Patients with a schizophrenia spectrum disorder have an increased risk of Parkinson's disease later in life. The study indicates that the increased risk may be due to alterations in the brain's ...
- Increased risk of Parkinson's disease in patients with schizophreniaon January 15, 2021 at 10:47 am
A new study conducted at the University of Turku, Finland, shows that patients with a schizophrenia spectrum disorder have an increased risk of Parkinson's disease later in life. The increased risk ...
- Peter Thiel-backed psychedelics start-up targets schizophrenia ahead of IPOon January 15, 2021 at 4:17 am
ATAI Life Science, a Peter Thiel-backed start-up, has taken a majority stake in Recognify, a company that is developing drugs to help treat schizophrenia.
- Full Trailer for Schizophrenia Film 'Fear of Rain' with Madison Isemanon January 14, 2021 at 4:00 pm
Your mind is just playing tricks on you." Lionsgate has revealed a second trailer for the indie psychological thriller Fear of Rain by filmmaker Castille Landon. A girl with schizophrenia struggles ...
- Psychiatric Nurses' Perceptions of Therapeutic Alliance With the Schizophrenia Population: A Survey Studyon January 14, 2021 at 6:44 am
Research on nurse–patient relationships with the schizophrenia population is sparse. The current study piloted a survey to explore therapeutic relationships. Fifty-one psychiatric nurses completed an ...
- Identical twins struggle with homelessness, schizophrenia on NYC streetson January 9, 2021 at 9:20 am
Laurie and Melissa Pittari grew up in a tight-knit family in New Orleans — both gifted students in high school, cellists in the city’s youth orchestra, with free rides to college. Identical ...
- David Bowie, the brother who lost his mind and the battle that's left his family raging: As his sibling's struggle with schizophrenia is touched on in a new biopic that's ...on January 8, 2021 at 4:41 pm
The release of a new David Bowie biopic should be a matter of great excitement for the late singer's devoted army of fans. But the film is mired in controversy.
- Schizophrenia- a deadly diseaseon January 7, 2021 at 6:41 pm
HEALTHWISEThe world has expanded discussions about mental health. The mental well-being of a human is as necessary as physical well-being, and the world seems to realize it since we have been ...
via Bing News